Cost-utility analysis of hepatitis a prevention among health-care workers in Israel

Keyphrases

• Israel 100%
• Healthcare Workers 100%
• Hepatitis A 100%
• Cost-utility Analysis 100%
• Mass Vaccination 66%
• Quality-adjusted Life Years 50%
• Paramedical Worker 50%
• Vaccination 16%
• Medical Literature 16%
• Primary Prevention 16%
• Medical Intervention 16%
• Hepatitis A Vaccine 16%
• Non-immune 16%
• Hepatitis A Virus 16%
• Seroepidemiological Survey 16%
• Model Assumptions 16%
• Selective Vaccination 16%
• Vaccine Price 16%
• Nurse Staff 16%
• Cost-effectiveness Analysis 16%
• Passive Immunization 16%
• Prior Vaccination 16%
• Paramedical Staff 16%
• Epidemiological Model 16%

Medicine and Dentistry

• Health Care Cost 100%
• Health Care 100%
• Hepatitis A 83%
• Mass Immunization 66%
• Quality Adjusted Life Year 50%
• Nurse 50%
• Cost-Effectiveness Analysis 16%
• Passive Immunization 16%
• Hepatitis A Vaccine 16%
• Primary Prevention 16%
• Medical Intervention 16%
• Hepatitis A Virus 16%

Nursing and Health Professions

• Health Care Personnel 100%
• Cost Utility Analysis 100%
• Hepatitis A 100%
• Mass Immunization 66%
• Quality Adjusted Life Year 50%
• Primary Prevention 16%
• Passive Immunization 16%
• Paramedical Personnel 16%
• Cost Effectiveness Analysis 16%
• Hepatitis A Vaccine 16%